BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15277636)

  • 1. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide.
    Levin N; Gomori JM; Siegal T
    Neurology; 2004 Jul; 63(2):354-6. PubMed ID: 15277636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
    Koukourakis GV; Kouloulias V; Zacharias G; Papadimitriou C; Pantelakos P; Maravelis G; Fotineas A; Beli I; Chaldeopoulos D; Kouvaris J
    Molecules; 2009 Apr; 14(4):1561-77. PubMed ID: 19384285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.
    Zhang J; Xiao X; Zhu J; Gao Z; Lai X; Zhu X; Mao G
    Int J Nanomedicine; 2018; 13():3039-3051. PubMed ID: 29861635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
    Mattox AK; Lark AL; Adamson DC
    Clin Neurol Neurosurg; 2012 May; 114(4):299-306. PubMed ID: 22341931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of diffuse and multi-lobes involved glioma with the assistance of a multimodal technique.
    Liu J; Chen H; Gao X; Cui M; Ma L; Zheng X; Guan B; Ma X
    Sci Rep; 2022 Feb; 12(1):3343. PubMed ID: 35228595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Glioma Cells Therapy Using ATRA-Induced Differentiation Method to Promote the Inhibitive Effect of TMZ and CCDP.
    Li X; Zou Z; Ma E; Feng S; Han S
    J Healthc Eng; 2021; 2021():6717582. PubMed ID: 34745507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.
    Ly KI; Oakley DH; Pine AB; Frosch MP; Chiou SH; Betensky RA; Pomerantz SR; Hochberg FH; Batchelor TT; Cahill DP; Dietrich J
    Oncologist; 2019 Mar; 24(3):402-413. PubMed ID: 30097523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliomatosis Cerebri: Current Understanding and Controversies.
    Ranjan S; Warren KE
    Front Oncol; 2017; 7():165. PubMed ID: 28824876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliomatosis cerebri: Case series of six cases with review of literature.
    Yerramneni VK; Vinjamuri SR; Purohit AK; Sundaram C
    J Neurosci Rural Pract; 2015; 6(4):602-6. PubMed ID: 26752659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas?
    Schaff LR; Lassman AB
    Semin Radiat Oncol; 2015 Jul; 25(3):203-9. PubMed ID: 26050591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procarbazine, CCNU, and Vincristine Chemotherapy in Gliomatosis Cerebri.
    Lee HG; Lee KS; Lee WH; Kim ST
    Brain Tumor Res Treat; 2014 Oct; 2(2):102-7. PubMed ID: 25408934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exclusive radiotherapy for gliomatosis cerebri: long-term follow-up at a single institution.
    Kim K; Chie EK; Park HJ; Kim DG; Jung HW; Park SH; Kim IH
    Clin Transl Oncol; 2014 Sep; 16(9):829-33. PubMed ID: 24474572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gliomatosis cerebri: a review.
    Rudà R; Bertero L; Sanson M
    Curr Treat Options Neurol; 2014 Feb; 16(2):273. PubMed ID: 24390814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliomatosis cerebri: clinical characteristics, management, and outcomes.
    Chen S; Tanaka S; Giannini C; Morris J; Yan ES; Buckner J; Lachance DH; Parney IF
    J Neurooncol; 2013 Apr; 112(2):267-75. PubMed ID: 23341100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic stratification of gliomatosis cerebri by IDH1 R132H and INA expression.
    Desestret V; Ciccarino P; Ducray F; Crinière E; Boisselier B; Labussière M; Polivka M; Idbaih A; Kaloshi G; von Deimling A; Hoang-Xuan K; Delattre JY; Mokhtari K; Sanson M
    J Neurooncol; 2011 Nov; 105(2):219-24. PubMed ID: 21516462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.
    Inoue T; Kumabe T; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
    Neurosurg Rev; 2010 Apr; 34(2):197-208. PubMed ID: 21301914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliomatosis cerebri presenting as a recurrent cervical myelopathy.
    Lima MA; Campos JC; Pessoa BL; Maranhão-Filho P; Lima GA; Barbosa AS; Lopes HF
    J Neurol; 2011 Mar; 258(3):510-2. PubMed ID: 20924592
    [No Abstract]   [Full Text] [Related]  

  • 18. Gliomatosis cerebri in young patients' report of three cases and review of the literature.
    Landi A; Piccirilli M; Mancarella C; Giangaspero F; Salvati M
    Childs Nerv Syst; 2011 Jan; 27(1):19-25. PubMed ID: 20376465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptomeningeal gliomatosis as the initial presentation of gliomatosis cerebri.
    Knox MK; Ménard C; Mason WP
    J Neurooncol; 2010 Oct; 100(1):145-9. PubMed ID: 20146082
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.